Research in my laboratory is focused on how cells cope with DNA damage. We aim to discover and characterize molecular responses that limit the emergence of genomic instability and consequently, limit cancer development. We also have an intense focus on understanding how DNA damaging therapeutics, such as radiotherapy, lead to cancer cure either alone or in combination with other treatments like immunotherapy. By leveraging these insights into the fundamental biology of cancer our goal is to improve detection, treatment, and survivorship for our patients. 

Dr. Harding is a Senior Scientist at the Princess Margaret Cancer Centre and Assistant Professor in the Department of Medical Biophysics at the University of Toronto. He received his Ph.D. in Medical Biophysics at the University of Toronto and completed his postdoctoral training at the University of Pennsylvania.

For a list of Dr. Harding's publications, please visit PubMed, Scopus, Publons or ORCID.

• Chair, Cancer Biology and Imaging Program, Princess Margaret Cancer Centre
• Co-Director, STARS21 Training program, Princess Margaret Cancer Centre
• Assistant Professor Department of Medical Biophysics, University of Toronto
• Assistant Professor Department of Radiation Oncology, University of Toronto
• Assistant Professor Department of Immunology, University of Toronto